Geopolitics Alpha

Market closed · last trade · ETF proxies, Alpaca IEX

8-K - Tvardi Therapeutics, Inc. (0001346830) (Filer)

Published . Updated .

Key takeaways

  • 8-K - Tvardi Therapeutics filed an 8-K with the SEC on Nov 19 (a notice of a material company event).
  • Exposed: TVRD, XLV, LLY, JNJ, ABBV
  • Market reaction: price tracking starts with the next trading session.

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

Get these market calls by email

The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.

Free. We only use your email to send the digest and never sell or share it. See our privacy policy.

GEOPOLITICS ALPHA8-K - Tvardi Therapeutics, Inc.(0001346830) (Filer)TVRDGEOPOLITICS ALPHA

8-K - Tvardi Therapeutics filed an 8-K with the SEC on Nov 19 (a notice of a material company event).

Directly affected

  • TVRD Tvardi Therapeutics

    Named in this report.

Indirectly affected

  • XLV Health Care Select Sector SPDR

    Health Care Select Sector SPDR holds the health sector that Tvardi Therapeutics belongs to, so it often moves with news about it.

  • LLY Eli Lilly and+25.1% 30d

    Eli Lilly and is a peer of Tvardi Therapeutics in pharmaceutical preparations; rivals often move on the same news.

  • JNJ Johnson & Johnson+12.1% 30d

    Johnson & Johnson is a peer of Tvardi Therapeutics in pharmaceutical preparations; rivals often move on the same news.

  • ABBV AbbVie+12.0% 30d

    AbbVie is a peer of Tvardi Therapeutics in pharmaceutical preparations; rivals often move on the same news.

  • MRK Merck+3.5% 30d

    Merck is a peer of Tvardi Therapeutics in pharmaceutical preparations; rivals often move on the same news.

  • ABT Abbott Laboratories+10.0% 30d

    Abbott Laboratories is a peer of Tvardi Therapeutics in pharmaceutical preparations; rivals often move on the same news.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
TVRD+7.01%+0.00%baseafter closeafter closeafter closeafter close
XLV+3.66%+3.71%baseafter closeafter closeafter closeafter close
LLY+3.43%+3.72%baseafter closeafter closeafter closeafter close
JNJ+3.98%+3.63%baseafter closeafter closeafter closeafter close
ABBV+2.96%+2.98%baseafter closeafter closeafter closeafter close
MRK+6.65%+4.90%baseafter closeafter closeafter closeafter close
ABT+2.66%+2.90%baseafter closeafter closeafter closeafter close

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

Filed: 2026-11-19 AccNo: 0001104659-26-129948 Size: 231 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Source: sec-edgar

Tvardi Therapeutics (TVRD) since this story, compared with the market

CompanyWhenMoveStatus
ABBVthree days earlier+2.98%final price
ABBVfive days earlier+2.96%final price
ABTthree days earlier+2.90%final price
ABTfive days earlier+2.66%final price
JNJthree days earlier+3.63%final price
JNJfive days earlier+3.98%final price
LLYthree days earlier+3.72%final price
LLYfive days earlier+3.43%final price
MRKthree days earlier+4.90%final price
MRKfive days earlier+6.65%final price
Tvardi Therapeutics (TVRD)three days earlier0.00%final price
Tvardi Therapeutics (TVRD)five days earlier+7.01%final price
XLVthree days earlier+3.71%final price
XLVfive days earlier+3.66%final price

Congressional trades in the stocks in this story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

Who gains and who loses around Tvardi Therapeutics (TVRD)

Companies mentioned with this story

  • TVRD Tvardi Therapeutics

    Tvardi Therapeutics (TVRD) is linked, with no stored direction, high confidence in the 19 Nov 2026 story “8-K - Tvardi Therapeutics, Inc. (0001346830) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> TVRD

How “8-K - Tvardi Therapeutics, Inc. (0001346830) (Filer)” reaches Tvardi Therapeutics (TVRD)

On 19 Nov 2026, “8-K - Tvardi Therapeutics, Inc. (0001346830) (Filer)” is the story that connects Tvardi Therapeutics (TVRD) to this story.

Tvardi Therapeutics (TVRD) is on the page because SEC 8-K filing -> direct issuer disclosure -> TVRD

How strong the case is around Tvardi Therapeutics (TVRD)

14 out of 100

“8-K - Tvardi Therapeutics, Inc. (0001346830) (Filer)” scores 14 out of 100. The score uses 1 source, and 1 linked company.